Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870; TTY/TDD Users 1-800-735-2258 - [E-mail Us]

DOCKETS ENTERED on 12/18/02

TABLE OF CONTENTS

Hyper links are part of the Docket  title - not all dockets/documents are linked

NOTE:  Documents received by the Dockets Management Branch "MAY" be posted on the Internet. PLEASE DO NOT include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence.

[FDA DOCKETS PAGE] [FDA HOME PAGE]  [ ITEM CODES ]

 
94P-0036 Req labeling of trans fatty acid & prohibit deceptive claims *
01N-0067 Reclassification of Dental Mercury *
02D-0350 Handling and Retention of Bioavailability and Bioequivalence *
02N-0417 Applications for FDA Approval to Market a New Drug *
02N-0445 FDA Regulation of Combination Products; Public Hearing *

94P-0036 Req labeling of trans fatty acid & prohibit deceptive claims

C 2287 Federal Trade Commission Vol#: 67

99P-5106 Identify Sources of Natural Flavorings

EMC 143 Ted Lowis Vol#: 2

00D-1598 Voluntary Labeling for Bioengineered Foods

EMC 11877 Nicole Suez Vol#: 426

EMC 11878 Darwin T. Agar Vol#: 426

00N-1396 Bioengineered Foods Consumed By Humans or Animals

EMC 11554 Nicole Suez Vol#: 349

EMC 11555 Darwin T. Agar Vol#: 349

01N-0067 Reclassification of Dental Mercury

ANS 8 HFW-1 to Honorable Pat Roberts Vol#: 15

EMC 640 Debbie Bevel Vol#: 10

EMC 641 Debbie Bevel Vol#: 10

EMC 642 Debbie Bevel Vol#: 10

EMC 643 Susan Bauer Vol#: 10

EMC 644 Susan Bauer Vol#: 10

EMC 645 Susan Bauer Vol#: 10

01P-0345 Listing the color additive yellow #5 for use in food/Drug

EMC 1152 Jacqui Hunnersen Vol#: 5

EMC 1153 Judith Webster Vol#: 5

EMC 1154 Jocelyn Robinson Vol#: 5

02D-0266 Guidance preventive measures to reduce risk of (CJD)

C 6 Marjorie Baker Vol#: 1

02D-0325 Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate

EMC 50 Melissa Laffer Vol#: 3

02D-0350 Handling and Retention of Bioavailability and Bioequivalence

C 9 Wyeth Research Vol#: 1

02N-0417 Applications for FDA Approval to Market a New Drug

C 3 Agvar Chemicals Inc. Vol#: 1

02N-0445 FDA Regulation of Combination Products; Public Hearing

TR 1 Transcript of 11/25/02 Hearing Vol#: 5

02N-0486 Prescription Drug Marketing Act of 1987

EMC 1 Judy Symcox Vol#: 1

EMC 2 Judy Symcox Vol#: 1

02P-0317 Recall Aspartame as a Neurotoxic Drug

EMC 71 Gloria Powell-Frederickson Vol#: 1

EMC 72 Marvin Lewis Vol#: 1

EMC 73 Julie Vol#: 1

EMC 74 Polly Remick Vol#: 1

EMC 75 Marylee Creegan Vol#: 1

EMC 76 Helen Wadle Vol#: 1

EMC 77 Jennifer Osborn Vol#: 1

EMC 78 Jocelyn Audet Vol#: 1

EMC 79 Mike & Darla Taylor Vol#: 1

EMC 80 Mike & Darla Taylor Vol#: 1

EMC 81 Donna Pettit Vol#: 1

EMC 82 AmyJane Stewart Vol#: 1

EMC 83 Laura Ruiz Vol#: 1

EMC 84 No signature Vol#: 1

EMC 85 Clare M. Joyner Vol#: 1

EMC 86 Ann Simon, RN Vol#: 1

EMC 87 No signature Vol#: 1

02V-0521 Laser Light Show

ACK 1 HFA-305 Vol#: 1

VAR 1 White Star Vol#: 1

02V-0522

VAR 1 Black Bear Jamboree Vol#: 1

02V-0523

ACK 1 HFA-305 Vol#: 1

VAR 1 Louisiana Arts and Science Museum Vol#: 1

02V-0524

ACK 1 HFA-305 Vol#: 1

VAR 1 Central Texas College Vol#: 1